Blood-based biomarkers of inflammation, such as neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), platelet-to-lymphocyte ratio (PLR), and lactate dehydrogenase (LDH) are routinely available biomarkers that have been widely investigated in different cancers (11–13). Here, CRP is linked to cancer.